These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 16902813

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Efficacy of aerosolized celecoxib encapsulated nanostructured lipid carrier in non-small cell lung cancer in combination with docetaxel.
    Patel AR, Chougule MB, I T, Patlolla R, Wang G, Singh M.
    Pharm Res; 2013 May; 30(5):1435-46. PubMed ID: 23361589
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Combined treatment of XIAP-targeting shRNA and celecoxib synergistically inhibits the tumor growth of non‑small cell lung cancer cells in vitro and in vivo.
    Zhang H, Li Z, Wang K, Ren P.
    Oncol Rep; 2015 Mar; 33(3):1079-88. PubMed ID: 25524805
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Synergistic antitumor efficiency of docetaxel and curcumin against lung cancer.
    Yin H, Guo R, Xu Y, Zheng Y, Hou Z, Dai X, Zhang Z, Zheng D, Xu H.
    Acta Biochim Biophys Sin (Shanghai); 2012 Feb; 44(2):147-53. PubMed ID: 22126905
    [Abstract] [Full Text] [Related]

  • 9. 15-Deoxy-Delta12,14-prostaglandin J2 enhances docetaxel anti-tumor activity against A549 and H460 non-small-cell lung cancer cell lines and xenograft tumors.
    Fulzele SV, Chatterjee A, Shaik MS, Jackson T, Ichite N, Singh M.
    Anticancer Drugs; 2007 Jan; 18(1):65-78. PubMed ID: 17159504
    [Abstract] [Full Text] [Related]

  • 10. Enhancement of antitumor activity of docetaxel by celecoxib in lung tumors.
    Shaik MS, Chatterjee A, Jackson T, Singh M.
    Int J Cancer; 2006 Jan 15; 118(2):396-404. PubMed ID: 16052515
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Death receptor regulation and celecoxib-induced apoptosis in human lung cancer cells.
    Liu X, Yue P, Zhou Z, Khuri FR, Sun SY.
    J Natl Cancer Inst; 2004 Dec 01; 96(23):1769-80. PubMed ID: 15572759
    [Abstract] [Full Text] [Related]

  • 14. Chemotherapy induces the expression of cyclooxygenase-2 in non-small cell lung cancer.
    Altorki NK, Port JL, Zhang F, Golijanin D, Thaler HT, Duffield-Lillico AJ, Subbaramaiah K, Dannenberg AJ.
    Clin Cancer Res; 2005 Jun 01; 11(11):4191-7. PubMed ID: 15930356
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of cyclooxygenase-2 inhibition in an orthotopic murine model of lung cancer for dose-dependent effect.
    Sievers EM, Bart RD, Backhus LM, Lin Y, Starnes M, Castanos R, Starnes VA, Bremner RM.
    J Thorac Cardiovasc Surg; 2005 Jun 01; 129(6):1242-9. PubMed ID: 15942563
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In vivo antitumor effects of chitosan-conjugated docetaxel after oral administration.
    Lee E, Kim H, Lee IH, Jon S.
    J Control Release; 2009 Dec 03; 140(2):79-85. PubMed ID: 19712714
    [Abstract] [Full Text] [Related]

  • 18. [Docetaxel and novel strategies in the treatment of NSCLC].
    Longo F, Mansueto G.
    Tumori; 2005 Dec 03; 91(6):suppl 11-22. PubMed ID: 16457162
    [No Abstract] [Full Text] [Related]

  • 19. Docetaxel and cyclooxygenase-2 inhibition with celecoxib for advanced non-small cell lung cancer progressing after platinum-based chemotherapy: a multicenter phase II trial.
    Nugent FW, Mertens WC, Graziano S, Levitan N, Collea R, Gajra A, Marshall J, McCann J.
    Lung Cancer; 2005 May 03; 48(2):267-73. PubMed ID: 15829328
    [Abstract] [Full Text] [Related]

  • 20. Formulation and evaluation of aerosolized celecoxib for the treatment of lung cancer.
    Haynes A, Shaik MS, Chatterjee A, Singh M.
    Pharm Res; 2005 Mar 03; 22(3):427-39. PubMed ID: 15835749
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.